Cargando…
A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the researc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497205/ https://www.ncbi.nlm.nih.gov/pubmed/34390213 http://dx.doi.org/10.1002/ehf2.13524 |
_version_ | 1784579905762099200 |
---|---|
author | Papageorgiou, Vasiliki Jones, Kathryn Halliday, Brian P. Mindham, Richard Bruton, Jane Wassall, Rebecca Cleland, John G.F. Prasad, Sanjay K. Ward, Helen |
author_facet | Papageorgiou, Vasiliki Jones, Kathryn Halliday, Brian P. Mindham, Richard Bruton, Jane Wassall, Rebecca Cleland, John G.F. Prasad, Sanjay K. Ward, Helen |
author_sort | Papageorgiou, Vasiliki |
collection | PubMed |
description | AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the research team (n = 4) from the TRED‐HF trial. Interviews were carried out in 2019 and were audio‐recorded and transcribed. Data were managed using NVivo and analysed using framework analysis. A patient representative provided guidance on the interpretation of findings and presentation of themes to ensure these remained meaningful, and an accurate representation, to those living with dilated cardiomyopathy. Three key themes emerged from the data: (i) perception of health; (ii) experiences and relationships with healthcare services and researchers; and (iii) perception of risk. Study participants held differing perceptions of their health; some did not consider themselves to have a heart condition or disagreed with the medical term ‘heart failure’. Relationships between participants, research staff, and clinical management teams influenced participants' experiences and decision making during the trial, including following clinical advice. There were differences in participants' perceptions of risk and their decisions to take heart failure medication after the trial was completed. Although the original TRED‐HF trial did not provide the results many had hoped for, a strong motivator for taking part was the opportunity to withdraw medication in a safely monitored environment which had been previously considered by some participants before. Investigators acknowledged that the insights gained from the study can now be used to support evidence‐based conversations with patients. CONCLUSIONS: For people whose dilated cardiomyopathy is in remission, decisions to continue, reduce, or stop their medication are influenced by perceptions of personal health, perceive risk and the important of work, employment, recreation, relationships, and long‐term plans. The unique relationship between patient and cardiologist provides opportunities to promote honest discussion about adherence to medication and personalized long‐term management. |
format | Online Article Text |
id | pubmed-8497205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84972052021-10-12 A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial Papageorgiou, Vasiliki Jones, Kathryn Halliday, Brian P. Mindham, Richard Bruton, Jane Wassall, Rebecca Cleland, John G.F. Prasad, Sanjay K. Ward, Helen ESC Heart Fail Original Research Articles AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the research team (n = 4) from the TRED‐HF trial. Interviews were carried out in 2019 and were audio‐recorded and transcribed. Data were managed using NVivo and analysed using framework analysis. A patient representative provided guidance on the interpretation of findings and presentation of themes to ensure these remained meaningful, and an accurate representation, to those living with dilated cardiomyopathy. Three key themes emerged from the data: (i) perception of health; (ii) experiences and relationships with healthcare services and researchers; and (iii) perception of risk. Study participants held differing perceptions of their health; some did not consider themselves to have a heart condition or disagreed with the medical term ‘heart failure’. Relationships between participants, research staff, and clinical management teams influenced participants' experiences and decision making during the trial, including following clinical advice. There were differences in participants' perceptions of risk and their decisions to take heart failure medication after the trial was completed. Although the original TRED‐HF trial did not provide the results many had hoped for, a strong motivator for taking part was the opportunity to withdraw medication in a safely monitored environment which had been previously considered by some participants before. Investigators acknowledged that the insights gained from the study can now be used to support evidence‐based conversations with patients. CONCLUSIONS: For people whose dilated cardiomyopathy is in remission, decisions to continue, reduce, or stop their medication are influenced by perceptions of personal health, perceive risk and the important of work, employment, recreation, relationships, and long‐term plans. The unique relationship between patient and cardiologist provides opportunities to promote honest discussion about adherence to medication and personalized long‐term management. John Wiley and Sons Inc. 2021-08-13 /pmc/articles/PMC8497205/ /pubmed/34390213 http://dx.doi.org/10.1002/ehf2.13524 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Articles Papageorgiou, Vasiliki Jones, Kathryn Halliday, Brian P. Mindham, Richard Bruton, Jane Wassall, Rebecca Cleland, John G.F. Prasad, Sanjay K. Ward, Helen A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title | A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title_full | A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title_fullStr | A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title_full_unstemmed | A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title_short | A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial |
title_sort | qualitative exploration of participant and investigator perspectives from the tred‐hf trial |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497205/ https://www.ncbi.nlm.nih.gov/pubmed/34390213 http://dx.doi.org/10.1002/ehf2.13524 |
work_keys_str_mv | AT papageorgiouvasiliki aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT joneskathryn aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT hallidaybrianp aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT mindhamrichard aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT brutonjane aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT wassallrebecca aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT clelandjohngf aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT prasadsanjayk aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT wardhelen aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT papageorgiouvasiliki qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT joneskathryn qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT hallidaybrianp qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT mindhamrichard qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT brutonjane qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT wassallrebecca qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT clelandjohngf qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT prasadsanjayk qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial AT wardhelen qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial |